The latest CPI report, a meeting between China’s President and Joe Biden, and the kick-off of retail earnings season. There are plenty of potential catalysts for markets next week, but which way will they send stocks? We’re digging in on the week ahead. Plus, Eli Lilly and Novo Nordisk might seemingly be hitting one new high after another, but why is Pfizer getting left in the dust? The Chart Master is here with his thoughts on where the drug giant is going next. 

 

Fast Money Disclaimer

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.